Your browser doesn't support javascript.
loading
Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from (223)Ra-dichloride to new horizons for therapeutic response assessment.
Bombardieri, Emilio; Evangelista, L; Ceresoli, G L; Boccardo, F.
Affiliation
  • Bombardieri E; Nuclear Medicine Department, Cliniche Humanitas Gavazzeni, Via Gavazzeni 21, 24125, Bergamo, Italy. emilio.bombardieri@gavazzeni.it.
  • Evangelista L; Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.
  • Ceresoli GL; Medical Oncology Department, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
  • Boccardo F; Academic Unit of Medical Oncology, IRCCS AOU San Martino-IST (San Martino University Hospital and National Cancer Research Institute), Genova, Italy.
Eur J Nucl Med Mol Imaging ; 43(1): 5-7, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26381776
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radium / Prostatic Neoplasms, Castration-Resistant / Nuclear Medicine Limits: Humans / Male Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2016 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radium / Prostatic Neoplasms, Castration-Resistant / Nuclear Medicine Limits: Humans / Male Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2016 Type: Article Affiliation country: Italy